Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | AP23464 |
Synonyms | |
Therapy Description |
AP23464 is a dual kinase inhibitor of Src and Abl, which is capable of inducing apoptosis and cell cycle arrest as well as inhibiting cellular proliferation (PMID: 15256422, PMID: 16492148, PMID: 17929114). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
AP23464 | BCR-ABL Inhibitor 31 SRC Inhibitor 31 | AP23464 is a dual kinase inhibitor of Src and Abl, which is capable of inducing apoptosis and cell cycle arrest as well as inhibiting cellular proliferation (PMID: 15256422, PMID: 16492148, PMID: 17929114). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|